Matches in Wikidata for { <http://www.wikidata.org/entity/Q64188416> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q64188416 description "clinical trial" @default.
- Q64188416 description "ensayu clínicu" @default.
- Q64188416 description "klinisch onderzoek" @default.
- Q64188416 description "клінічне випробування" @default.
- Q64188416 name "Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A" @default.
- Q64188416 type Item @default.
- Q64188416 label "Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A" @default.
- Q64188416 prefLabel "Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A" @default.
- Q64188416 P1132 Q64188416-B5797015-2FE5-411F-8B3E-06050EED71E8 @default.
- Q64188416 P1476 Q64188416-8A7D272F-1707-40E6-B86B-EFC1E0045633 @default.
- Q64188416 P17 Q64188416-02DA7FE5-17B9-4271-A224-07A02EEA2871 @default.
- Q64188416 P17 Q64188416-23BEAB82-37CC-40D4-8016-DC06ED3D12E1 @default.
- Q64188416 P17 Q64188416-97C151D4-20BC-4814-9F34-2499D2243CA0 @default.
- Q64188416 P2899 Q64188416-B991D137-E802-4519-AC38-691C220B90DF @default.
- Q64188416 P3098 Q64188416-A10AFA8E-04ED-4C93-A74E-DA2FF0C71961 @default.
- Q64188416 P31 Q64188416-65C828B9-A560-44D8-BA1E-B4F0E1F15E1E @default.
- Q64188416 P4135 Q64188416-1AE9333B-64FE-43D6-BB64-EB55B96C9C1D @default.
- Q64188416 P4844 Q64188416-5D6CB4AC-D79E-499D-93AA-DA71983575F3 @default.
- Q64188416 P4844 Q64188416-72C4CF33-7ADC-4EF2-96BF-4CB19AB6C24E @default.
- Q64188416 P4844 Q64188416-8BAACD84-629B-4870-A9D0-5EFD8070E212 @default.
- Q64188416 P4844 Q64188416-92364501-B76F-480B-A6BC-58647FEDF940 @default.
- Q64188416 P4844 Q64188416-A2D291D4-0CEB-4176-9346-7EFC0DD1AECD @default.
- Q64188416 P4844 Q64188416-D7DBC7BB-21FD-4CC5-BCA7-63C411F30BAD @default.
- Q64188416 P580 Q64188416-7B4C0847-75E4-4156-8BD4-C74361BBF397 @default.
- Q64188416 P582 Q64188416-DBE8B6B4-275D-4FCC-852D-2D7879811671 @default.
- Q64188416 P6099 Q64188416-2057946C-1A77-47F5-B463-36BDE28F5DAE @default.
- Q64188416 P8363 Q64188416-FF2E4804-D524-4D0E-9838-3553FB02CF9A @default.
- Q64188416 P859 Q64188416-B94E2AC2-5585-4A37-952B-A3F369769384 @default.
- Q64188416 P1132 "+122" @default.
- Q64188416 P1476 "An Open-Label, Multinational, Multicenter, Phase IIIB Study to Assess Safety of Rituximab Following Subcutaneous Administration in Patients With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A" @default.
- Q64188416 P17 Q1028 @default.
- Q64188416 P17 Q262 @default.
- Q64188416 P17 Q948 @default.
- Q64188416 P2899 "+18" @default.
- Q64188416 P3098 "NCT02406092" @default.
- Q64188416 P31 Q30612 @default.
- Q64188416 P4135 "+80" @default.
- Q64188416 P4844 Q185916 @default.
- Q64188416 P4844 Q18936 @default.
- Q64188416 P4844 Q29004943 @default.
- Q64188416 P4844 Q408524 @default.
- Q64188416 P4844 Q412323 @default.
- Q64188416 P4844 Q424972 @default.
- Q64188416 P580 "2015-10-13T00:00:00Z" @default.
- Q64188416 P582 "2021-05-20T00:00:00Z" @default.
- Q64188416 P6099 Q42824827 @default.
- Q64188416 P8363 Q78089383 @default.
- Q64188416 P859 Q212646 @default.